Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026 ⊖
found
a story from The Guardian ⚠️ › International
Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition
The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in reven…